approval
saveMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approval
community read0 votes
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalMEKINIST (TRAMETINIB) — FDA approvalMar 26, 2026 · 193d ago
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalMar 26, 2026 · 193d ago
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalApr 21, 2025 · 532d ago
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalApr 7, 2025 · 546d ago
- approvalMEKINIST (TRAMETINIB) — FDA approvalApr 7, 2025 · 546d ago
- approvalMEKINIST (TRAMETINIB) — FDA approvalMar 19, 2025 · 565d ago
- approvalMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalMar 19, 2025 · 565d ago
- approvalMEKINIST (TRAMETINIB) — FDA approvalMar 7, 2025 · 577d ago
same company · ±60 days · 5
- approvaldabrafenib mesylate ODT: TAFINLAR (DABRAFENIB MESYLATE) — FDA approvalJun 22, 2022
- approvalinclisiran: LEQVIO (INCLISIRAN SODIUM) — FDA approvalJun 6, 2022
- approvalSpexotras: MEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalMay 27, 2022
- approvaldabrafenib mesylate ODT: TAFINLAR (DABRAFENIB MESYLATE) — FDA approvalMay 27, 2022
- approvalImatinib Mesylate Shilpa: GLEEVEC (IMATINIB MESYLATE) — FDA approvalAug 19, 2022
comments(0)
5-min edit window · permanent after that